The table below shows Surgery Partners, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$11.70M
$6.00M
$40.70M
$74.50M
$79.80M
$50.20M
Capital expenditure
$16.00M
$22.70M
$21.00M
$24.30M
$18.20M
$14.50M
Investing cash flow
-$13.40M
-$76.40M
-$83.10M
-$70.70M
-$47.10M
-$14.30M
Dividends paid
-
-
-
-
SGRY operating cash flow (10-K history)
Surgery Partners, Inc. reported operating cash flow of $274.30M for fiscal year 2025. That is down 8.6% from $300.10M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $84.48M (FY 2015) to $274.30M. Figures come from the company's audited annual reports as filed with the SEC.
